医薬 市場調査レポート

このリストでは医薬市場に関する調査レポートを新刊順に紹介しています。
例えば、薬学的薬物、生化学的薬物、バイオ薬物、抗感染性薬物といった分野の動向に関する調査レポート (技術動向、市場規模予測)を紹介しています。又、調剤薬、診断薬、公衆衛生用薬、治療を主目的としない薬物に関する調査レポートも紹介しています。

転移性膵がん (腫瘍学) - 開発段階の治療薬　2021年

Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021SummaryMetastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Pancreatic Cancer pipeline landscape.The report provides comprehensive i…

このレポートの詳細ページはこちら

転移性卵巣がん (腫瘍学) - 開発段階の治療薬　2021年

Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021SummaryMetastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Ovarian Cancer pipeline landscape.The report provides comprehensive informatio…

このレポートの詳細ページはこちら

転移性前立腺がん (腫瘍学) - 開発段階の治療薬　2021年

Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021SummaryMetastatic Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Prostate Cancer pipeline landscape.The report provides comprehensive informa…

このレポートの詳細ページはこちら

転移性腎細胞がん (腫瘍学) - 開発段階の治療薬　2021年

Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021SummaryMetastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Renal Cell Carcinoma pipeline landscape.The report provides compre…

このレポートの詳細ページはこちら

転移性黒色腫 (腫瘍学) - 開発段階の治療薬　2021年

Metastatic Melanoma (Oncology) - Drugs in Development, 2021

価格　US$ 2,500　｜　 Global Markets Direct　｜　―

Metastatic Melanoma (Oncology) - Drugs in Development, 2021SummaryMetastatic Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Melanoma pipeline landscape.The report provides comprehensive information on the therapeut…

このレポートの詳細ページはこちら

中枢神経系 (CNS) がん (腫瘍学) - 開発段階の治療薬　2021年

Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Central Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021SummaryCentral Nervous System (CNS) Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Central Nervous System (CNS) Cancer pipeline landscape.The report pro…

このレポートの詳細ページはこちら

唾液腺がん (腫瘍学) - 開発段階の治療薬　2021年

Salivary Gland Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Salivary Gland Cancer (Oncology) - Drugs in Development, 2021SummarySalivary Gland Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Salivary Gland Cancer pipeline landscape.The report provides comprehensive information on the the…

このレポートの詳細ページはこちら

成長ホルモン欠乏 (欠損) 症 (代謝障害) - 開発段階の治療薬　2021年

Growth Hormone Deficiency (Metabolic Disorders) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Growth Hormone Deficiency (Metabolic Disorders) - Drugs in Development, 2021SummaryGrowth Hormone Deficiency (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Growth Hormone Deficiency pipeline landscape.The report provides co…

このレポートの詳細ページはこちら

髄膜腫 (腫瘍学) - 開発段階の治療薬　2021年

Meningioma (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Meningioma (Oncology) - Drugs in Development, 2021SummaryMeningioma (Oncology) - Drugs in Development, 2021 provides an overview of the Meningioma pipeline landscape.The report provides comprehensive information on the therapeutics under development for M…

このレポートの詳細ページはこちら

腎細胞がん (腫瘍学) - 開発段階の治療薬　2021年

Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021

価格　US$ 2,500　｜　 Global Markets Direct　｜　―

Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021SummaryRenal Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Renal Cell Carcinoma pipeline landscape.The report provides comprehensive information on the therap…

このレポートの詳細ページはこちら

心内膜炎 (循環器) - 開発段階の治療薬　2021年

Endocarditis (Cardiovascular) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Endocarditis (Cardiovascular) - Drugs in Development, 2021SummaryEndocarditis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Endocarditis pipeline landscape.The report provides comprehensive information on the therapeutics under…

このレポートの詳細ページはこちら

心筋症 (循環器) - 開発段階の治療薬　2021年

Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021SummaryCardiomyopathy (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Cardiomyopathy pipeline landscape.The report provides comprehensive information on the therapeutics…

このレポートの詳細ページはこちら

食物アレルギー (免疫学) - 開発段階の治療薬　2021年

Food Allergy (Immunology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Food Allergy (Immunology) - Drugs in Development, 2021SummaryFood Allergy (Immunology) - Drugs in Development, 2021 provides an overview of the Food Allergy pipeline landscape.The report provides comprehensive information on the therapeutics under develop…

このレポートの詳細ページはこちら

食道胃接合部腺がん (腫瘍学) - 開発段階の治療薬　2021年

Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021

価格　US$ 2,500　｜　 Global Markets Direct　｜　―

Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021SummaryAdenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021 provides an overview of the Adenocarcinoma Of The Gastroesophageal Juncti…

このレポートの詳細ページはこちら

上皮性卵巣がん (腫瘍学) - 開発段階の治療薬　2021年

Epithelial Ovarian Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,500　｜　 Global Markets Direct　｜　―

Epithelial Ovarian Cancer (Oncology) - Drugs in Development, 2021SummaryEpithelial Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Epithelial Ovarian Cancer pipeline landscape.The report provides comprehensive informatio…

このレポートの詳細ページはこちら

上衣腫 (腫瘍学) - 開発段階の治療薬　2021年

Ependymoma (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Ependymoma (Oncology) - Drugs in Development, 2021SummaryEpendymoma (Oncology) - Drugs in Development, 2021 provides an overview of the Ependymoma pipeline landscape.The report provides comprehensive information on the therapeutics under development for E…

このレポートの詳細ページはこちら

子癇前症 (循環器) - 開発段階の治療薬　2021年

Pre-Eclampsia (Cardiovascular) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Pre-Eclampsia (Cardiovascular) - Drugs in Development, 2021SummaryPre-Eclampsia (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Pre-Eclampsia pipeline landscape.The report provides comprehensive information on the therapeutics un…

このレポートの詳細ページはこちら

再発性慢性リンパ球性白血病 (CLL) (腫瘍学) - 開発段階の治療薬　2021年

Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021SummaryRelapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) pipeline …

このレポートの詳細ページはこちら

再発性多形性膠芽腫 (GBM) (腫瘍学) - 開発段階の治療薬　2021年

Recurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021

価格　US$ 2,500　｜　 Global Markets Direct　｜　―

Recurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021SummaryRecurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021 provides an overview of the Recurrent Glioblastoma Multiforme (GBM) pipeline landscape.Th…

このレポートの詳細ページはこちら

再発急性骨髄性白血病 (腫瘍学) - 開発段階の治療薬　2021年

Relapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021

価格　US$ 2,500　｜　 Global Markets Direct　｜　―

Relapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021SummaryRelapsed Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the Relapsed Acute Myeloid Leukemia pipeline landscape.The report provides compre…

このレポートの詳細ページはこちら